Moving Health Care into the Future: Proposal for Pharmacist-led Refill Authorizations


Pharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.


Over recent decades, the role of the pharmacist has grown to include various direct patient care activities as the profession becomes more integrated into health care provider teams.1 With the increasing shortage of primary care physicians in America, the FDA is considering the expansion of pharmacists’ scope of practice. Pharmacists in Canada and the United Kingdom are already permitted to authorize medication refills, which has not only led to a reduction in medication related errors but has also relieved pressure from overwhelmed providers.3


Pharmacists may implement refill authorization services in retail pharmacies by establishing Collaborative Drug Therapy Management (CDTM) agreements with physicians. CDTM is defined as an agreement between physicians and pharmacists whereby pharmacists may initiate, monitor, continue, and adjust drug therapy for certain disease states based on established protocols.4 Of the 50 states, 47 currently allow pharmacists to establish a collaborative practice agreement with physicians;5 however, these agreements have not been extensively established within retail settings.

The workflow models of various refill authorization programs exemplify protocols and procedures that could reasonably be adopted in all retail pharmacies.6-9 Upon receiving a request for additional refills, a pharmacist can first determine whether they can safely evaluate the medication for continuation of therapy.10 Such medications are generally for chronic disease states that have been deemed appropriate for pharmacist management in a collaborative practice agreement.

Examples of chronic diseases that may benefit from pharmacist oversight include hypertension, diabetes, hyperlipidemia, hypothyroidism, asthma/COPD, allergies, epilepsy, and depression.4,6,8 Next, the pharmacist retrieves the patient’s electronic medical record and reviews important lab values, vitals, refill dates, lab dates, and dates of physician visits in order to assess disease progression, medication history, appropriateness of monitoring parameters, and follow-up history.6-9

Afterward, the pharmacist may interview the patient to gather pertinent safety and efficacy-related information about the medication.8,9

Pharmacists may utilize decision algorithms that outline safety and efficacy requirements for each drug class to facilitate consistent and reliable decision-making during a point-of-care service, as done in a US Navy Hospital Refill Clinic.8 Subsequently, if a pharmacist determines that no drug therapy problems exist, they may authorize additional refills for a certain duration, as specified in the CDTM agreement.

Research protocols enabled refill authorizations for durations varying from 30 days to 12 months.6-9 If the patient lacks a lab parameter or provider visit within the past year, the pharmacist may schedule the necessary lab or physician appointment and authorize sufficient refills until that date.6,9

However, if a pharmacist detects a drug therapy problem that would preclude continuation of therapy, they would contact the patient’s doctor and relay the need for reconciliation.6,8,9

Pharmacist-led refill authorizations are advantageous for both health care providers and patients. As a result of diminishing physician supply, the Unites States has “fewer physician visits than the [global] median (4.0 vs 6.5)” respectively.7 Hence, patients are at risk of gaps in care due to delayed appointments with their primary care physician.10-13

Furthermore, requests for refill renewals are inconvenient, causing missed doses for the patient, while disrupting workflow and increasing administrative tasks for both pharmacists and physicians.2,11,12,14-16

Pharmacist-led refill authorization programs can thus bridge gaps in health care as well as “expedite the refill process, alleviate provider time spent on refill requests, and promote patient safety.”17

Pharmacists’ refill services have demonstrated greater optimization of therapy compared with usual care. For example, a Canadian study found that pharmacists identified significantly greater drug-related problems, rectified more regimens and increased the number of routine appointments when evaluating refills.18

A Kaiser Permanente experiment also demonstrated that pharmacist-led refill authorizations yielded a greater percentage of patients with adequate medication monitoring compared with physician-led authorizations (49% vs 29%).6 Another Kaiser Permanente site instituting a new medication refill protocol with pharmacist involvement, demonstrated a 15% increase in medication compliance after initiating the program.19

Furthermore, a US Navy Refill Clinic showed that pharmacists were able to increase quality of care by identifying adverse events and drug interactions while also improving adherence and treatment cost by reducing the number of medications a patient takes and by suggesting lower cost alternatives.8

Pharmacist-led refill authorization programs can yield monetary benefits through cost-savings. One 30-day study serving 32 patients in a pharmacist refill clinic calculated a $1235 cost savings, not including the benefits offset by employing a pharmacist rather than a physician.6

This amounts to $38.59 saved per patient per month. Furthermore, a 2001-2002 study of a Navy Hospital showed a total $70,691 savings for the 573 patients that were cared for by a pharmacist versus a physician.8 In addition, since medication nonadherence contributes to 10% of hospitalizations and up to $300 billion in health care spending, the role of pharmacists in improving adherence rates through refill authorizations can help to reduce hospitalization-related costs as well.20

As with any move towards change, there are deterrents hindering the implementation of pharmacist-led refill authorizations. For example, doctors and patients are skeptical of pharmacist involvement due to the belief that they are not sufficiently qualified to make clinical decisions. However, this doubt is rooted in the lack of knowledge on the roles and responsibilities of pharmacists.

One study surveyed patients’ beliefs on the competence of pharmacists before and after a public service announcement video, which found that patients significantly increased their ratings on the capability of pharmacists to manage medications after being informed of their duties.21 In addition, an annual poll conducted by Gallup has found that Americans consider pharmacists among the most trusted professionals, having consistently ranked them among the top 3 most honest and ethical professionals over the last 14 years.22

This trust can help pharmacists establish new clinical roles and relationships with patients. Although some say that providers are also unwilling to trust pharmacists to refill medications, this has been refuted through experiments in which pharmacists’ decisions were consistently supported and trusted by physicians.3,15,23

Moreover, physicians may develop trust in pharmacists’ patient care involvement by first initiating a working rapport with each other and by establishing certain limits on pharmacists’ clinical scope within mutually agreed upon CDTM protocols. Furthermore, the strictly collaborative nature of a pharmacist-led refill authorization program can serve to remove any doubts about pharmacists potentially disrupting physician duties.

Another hindrance to expansion is the lack of access to patient's electronic medication administration records (EMAR). This can be solved by making EMAR available for pharmacists.23-25

A study conducted by Price et al designed a program that added pharmacists into the EMAR system so that they were privy to patient information as their health status changed.24

This study design can be applied to the community setting in the same way that electronic prescriptions have become prevalent in community pharmacies.25 The availability of EMAR is so crucial to health care that the Center for Medicare and Medicaid Services has announced recommendations on how to “support health information exchange (HIE) and interoperable systems” through funds from the Health Information Technology for Economic and Clinical Health Act.26

Among the most prevalent arguments against pharmacist-led refill authorizations is the prospect of increasing workload for community pharmacists. Some argue that community pharmacists already struggle to keep up with current demands in the pharmacy.6,27

Although it is true that refill authorizations would be another addition to the pharmacist’s daily tasks, the time commitment can be managed by reorganizing responsibilities within the pharmacy. As technicians are being encouraged to increase their knowledge and obtain licensure, they become an ideal resource to delegate administrative and production tasks in the pharmacy when new services are implemented.28

In addition, a study conducted by Dosea et al found that community pharmacists were happy to expand their services in an effort to “consolidate” their responsibilities with the clinical knowledge they were taught in training.29

The current lack of reimbursement to pharmacies for patient care interventions is a crucial deterrent against the implementation of pharmacist-led refill authorizations. Since pharmacists are not designated with provider status within the legislature, they are unable to bill Medicare for patient care.30

Without the ability to produce revenue from a refill authorization program, pharmacies lack a monetary incentive to implement such a program. The American Society of Health-Systems Pharmacists advocates for legislative change by asserting that the payment needed to reimburse pharmacists for their services is “less than the average monthly salary of a pharmacist,” while the amount of health care costs saved through pharmacists’ clinical services is “two to three times greater than their annual salary.”30


Pharmacist-led refill authorizations can benefit many components of our current health care system. A multitude of evidence demonstrates that pharmacist-led refill authorizations optimize patients’ therapies and yield cost-savings.32

Access to patients’ medical records and reimbursement for services would therefore enable pharmacists to not only improve the quality of patient care, but also reduce overall health care costs. These programs also benefit physicians by allowing them to better focus on more complex patient cases. Hence, expanding the role of pharmacists in authorizing prescription refills is a logical step in improving health care for Americans.

About the Authors

Todd A Brown is clinical instructor and vice chair, Bouvé College of Health Sciences, Department of Pharmacy Education, Northeastern University, 617-373-4175, Email

Riza Usta and Nazmin J Khalifa are PharmD students, Bouvé College of Health Sciences, Northeastern University.


  • Isasi F, Krofah E. The Expanding Role of Pharmacists in a Transformed Healthcare System [Internet]. Washington DC: National Governors Association Center for Best Practices; 2015 Jan 13 [cited 2016Jan20]. Available from:
  • Kulkarni D. Should Pharmacists Be Given Expanded Dispensing Powers? [Internet]. Plainsboro (NJ): Pharmacy Times. Pharmacy & Healthcare Communications; 2012 May 10 [cited 2016Jan20]. Available from:
  • Collins S. A tale of two countries: The path to pharmacist prescribing in the United Kingdom and Canada.[Internet]. Washington DC: American Pharmacists Association. 2014 Mar 1 [cited 2016Jan23]; Available from from:
  • Select Features of State Pharmacist Collaborative Practice Laws [Internet]. Atlanta (GA): Centers for Disease Control and Prevention, 2013 Dec. [cited 2015 Nov. 20]. Available from:
  • Ehrich R. Pharmacist Scope of Services [Internet]. Washington DC: American Pharmacist Association. [cited 23 Jan. 2016]. Available from:
  • Billups SJ, Delate T, Newlon C, Schwiesow S, Jahnke R, Nadrash A. Outcomes of a pharmacist-managed medication refill program. J Am Pharm Assoc. 2013 Oct;53(5):505—12.
  • Bunting BA, Smith BH, Sutherland SE. The Asheville Project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23—31.
  • Riege VJ. A Patient Safety Program & Research Evaluation of U.S. Navy Pharmacy Refill Clinics. In: Henriksen K, Battles JB, Marks ES, et al., editors. Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb. Available from:
  • Lam AY, Rose D. Telepharmacy Services In An Urban Community Health Clinic System. J Am Pharm Assoc. 2009 Oct 49(5): 652-659.
  • Collaborative Practice Agreements and Pharmacists’ Patient Care Services: A Resource for Pharmacists [Internet]. Atlanta (GA): US Dept. of Health and Human Services, Centers for Disease Control and Prevention. 2013 Oct. [cited 2016 Jan 20]. Available from:
  • Jones RJ, Goldman MP, Rockwood RP, Imhoff TE. Beneficial Effect Of A Pharmacist Refill Evaluation Clinic. Hospital Pharmacy. 1987 Feb 22(2)
  • Nietert PJ, Tilley BC, Zhao W, Edwards PF, Wessell AM, Mauldin PD, et al. Two Pharmacy Interventions to Improve Refill Persistence for Chronic Disease Medications. Medical Care. 2009 Jan;47(1):32—40.
  • Talley CR. Prescribing authority for pharmacists. American Journal of Health-System Pharmacy [Internet]. 2011 Dec 15 [cited 2016 Jan 21]; 68(24): 2333. Available from:
  • Cassidy IB, Keith MR, Coffey EL, Noyes MA. Impact Of Pharmacist-Operated General Medicine Chronic Care Refill Clinics On Practitioner Time And Quality Of Care. The Annals Of Pharmacotherapy. 1996 Jul-Aug; 30(7-8) 30.7-8: 745-751.
  • Teichman P, Teichman A. Rethinking Your Approach to Prescription "refills". Fam Pract Manag [Internet]. 2011 Nov- Dec [cited 2016 Jan 20]; 18(6): 16-19. Available from:
  • Honesty/Ethics in Professions [Internet]. Gallup. 2015 Dec 2 [cited 2016 Mar 12]. Available from:
  • Pharmacist Scope of Practice [Internet]. Public Health Law Research. 2015 Jan 1 [cited 2016 Jan 29]. Available from:
  • McKinnon A, Jorgenson D. Pharmacist and Physician Collaborative Prescribing For Medication Renewals within a Primary Health Centre. Canadian Family Physician [Internet]. 2009 Dec [cited 2016 Jan 20]; 55(12): 86-91. Available from:
  • Frandzel S. Kaiser Refill Protocol Expands Pharmacist Scope of Practice. Ashpintersectionsorg. 2015. Available at: Accessed December 19, 2016.
  • McGuire MIuga. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35-44. doi:10.2147/rmhp.s19801.
  • Perepelkin J, Abramovic M. Public Education Campaigns to Transform Perceptions of Pharmacists: Are They Worth the Investment?. Health Commun. 2015 Dec 7;:1-12
  • Pharmacists Rank High on Gallup's Poll of Most Trusted Professionals - NASPA. NASPA. 2017. Available at: Accessed December 22, 2016.
  • Keller ME, Kelling SE, Cornelius DC, Oni HA, Bright DR. Enhancing Practice Efficiency and Patient Care by Sharing Electronic Health Records. Perspect Health Inf Manag. 2015 Nov 01; 12:1b.
  • Price M, Weber J, Davies I, Bellwood P. Lead User Design: Medication Management in Electronic Medical Records. Stud Health Technol Inform. 2015; 216: 237-41.
  • Held AD, Woodall LJ, Hertig JB. Pharmacists’ Familiarity, Utilization, and Beliefs about Health Information Exchange: A Survey of Pharmacists in an Indiana Pharmacy Organization. J Am Pharm Assoc. 2014 Nov-Dec; 54 (6): 625-9.
  • Balick R. HIT: Pharmacists May Be Eligible for Matching Funds [Internet]. Washington DC: American Pharmacists Association. 2016 March 22 [cited 2016 Apr 6]. Available from:
  • Witry MJ, Doucette WR. Community Pharmacists, Medication Monitoring, and the Routine Nature of Refills: A Qualitative Study. J Am Pharm Assoc. 2014 Nov-Dec; 54(6): 594-603.
  • Meade D. Pharmacist’s Letter Presents Interactive Session on the Evolving Role of Pharmacy Technicians at APhA [Internet]. San Diego (CA): BusinessWire. 2015 March 03 [cited 2016 Apr 13]. Available from:’s-Letter-Presents-Interactive-Session-Evolving-Role
  • Dosea AS, Brito CG, Santos LMC, Marques TC, Balisa-Rocha B, Pimentel D, et al. Establishment, Implementation, and Consolidation of Clinical Pharmacy Services in Community Pharmacies: Perceptions of a Group of Pharmacists. Qual Health Res. 2015 Dec 10
  • Dole E, Murawski M. Is Prescribing the Next Step in the Evolution of Pharmacy? [Internet] American Society of Health Systems Pharmacy; 2012 May 15 [cited 2016 Jan 22]. Available from:
  • Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient Evaluation of a Community Pharmacy Medications Management Service. Ann Pharmacother. 2007 Dec; 41(12): 1962-970.

Recent Videos
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny -
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 -
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
© 2024 MJH Life Sciences

All rights reserved.